๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Risk of second primary malignancies in patients with cutaneous melanoma

โœ Scribed by M-H. Schmid-Wendtner; J. Baumert; C-M. Wendtner; G. Plewig; M. Volkenandt


Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
68 KB
Volume
145
Category
Article
ISSN
0007-0963

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Risks of second primary malignancy in pa
โœ A. J. Swerdlow; H. H. Storm; P. D. Sasieni ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 780 KB

Risks of 2nd primary cancer were assessed in all patients with cutaneous melanoma (I 2,460) and all patients with ocular melanoma (2,O 18) incident in Denmark from I943 to I989 and followed for totals of 88,667 person-years and 16,045 personyears, respectively. After cutaneous melanoma, 972 2nd canc

Second primary tumors in patients with c
โœ Smita Bhatia; Lilian Estrada-Batres; Tamara Maryon; Monica Bogue; David Chu ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 81 KB ๐Ÿ‘ 2 views

Several studies report coexistent or subsequent primary tumors (SPT) among patients with malignant melanoma (MM), with the rate of incidence ranging from 1.5-20% depending on the sample size and the length and completeness of follow-up. ## METHODS. The authors followed a cohort of patients with c

The risk of subsequent primary carcinoma
โœ Maryjean Schenk; Richard K. Severson; Karen S. Pawlish ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 69 KB ๐Ÿ‘ 3 views

## Background: Carcinoma of the pancreas is the fifth leading cancer in the u.s. and has the poorest survival rate of the major malignancies. recent studies have reported an increased risk of carcinoma of the pancreas in malignant melanoma-prone kindreds and have suggested a link between malignant

A population-based analysis of risk fact
โœ William B. Goggins; Hensin Tsao ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 79 KB ๐Ÿ‘ 2 views

## Abstract ## BACKGROUND The results of several studies have provided evidence that patients diagnosed with cutaneous melanoma (CM) are at a higher risk of developing a second primary CM than the general population. In this study, the authors examined how the risk of a second primary tumor varied